2. Academic Validation
  3. Eosinophilic esophagitis

Eosinophilic esophagitis

  • Ann Allergy Asthma Immunol. 2014 May;112(5):397-403. doi: 10.1016/j.anai.2014.01.023.
Jamie Merves 1,  Amanda Muir 1,  Prasanna Modayur Chandramouleeswaran 1,  Antonella Cianferoni 2,  Mei-Lun Wang 1,  Jonathan M Spergel 3
Affiliations

Affiliations

  • 1 Division of Gastroenterology and Nutrition, The Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
  • 2 Division of Allergy and Immunology, The Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
  • 3 Division of Allergy and Immunology, The Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia. Electronic address: spergel@email.chop.edu.
PMID: 24566295 DOI: 10.1016/j.anai.2014.01.023
Abstract

Objective: To review the understanding of the pathogenesis of eosinophilic esophagitis (EoE) and the role of the immune system in the disease process.

Data sources: Peer-reviewed articles on EoE from PubMed searching for "Eosinophilic Esophagitis and fibrosis" in the period of 1995 to 2013.

Study selections: Studies on the clinical and immunologic features, pathogenesis, and management of EoE.

Results: Recent work has revealed that thymic stromal lymphopoietin and basophil have an increased role in the pathogenesis of disease. Additional understanding on the role of fibrosis in EoE is emerging.

Conclusion: The incidence of EoE is increasing like most atopic disease. Similar to other allergic diseases, EoE is treated with topical Steroids and/or allergen avoidance.

Figures